Skip to main content
. Author manuscript; available in PMC: 2020 Sep 28.
Published in final edited form as: Cancer. 2015 Sep 22;121(24):4398–4406. doi: 10.1002/cncr.29669

TABLE 3.

Characteristics of Newly Diagnosed AYAs (Aged 15–39 Years) Enrolled Versus Those Not Enrolled onto Therapeutic and Nontherapeutic Cancer Studies (Across All Institutions)

Therapeutic
Nontherapeutic
Enrolled Not Enrolled P Enrolled Not Enrolled P
Age, y
 15–19 31 (12%) 237 (88%) <.01 90 (34%) 178 (66%) <.01
 20–24 10 (4%) 241 (96%) 14 (6%) 237 (94%)
 25–29 16 (5%) 290 (95%) 30 (10%) 276 (90%)
 30–34 14 (4%) 357 (96%) 69 (19%) 302 (81%)
 35–39 33 (7%) 470 (93%) 84 (17%) 419 (83%)
Sex
 Male 48 (6%) 812 (94%) .35 107 (12%) 753 (88%) <.01
 Female 56 (7%) 783 (93%) 180 (21%) 659 (79%)
Race/ethnicity
 White, non-Hispanic 13 (4%) 340 (96%) .06 38 (11%) 315 (89%) <.01
 African American 2 (3%) 78 (97%) 6 (7%) 74 (93%)
 Hispanic 77 (7%) 1011 (93%) 212 (19%) 876 (81%)
 Asian/Pacific Islander 12 (7%) 166 (93%) 31 (17%) 147 (83%)
Hospital
 Children’s hospital 29 (15%) 162 (85%) <.01 87 (46%) 104 (54%) <.01
 Adult cancer hospital 10 (3%) 310 (97%) 30 (9%) 290 (91%)
 Public hospital 65 (5%) 1123 (95%) 170 (14%) 1018 (86%)
Diagnosis
 Extracranial germ cell tumor 7 (3%) 237 (97%) <.01 12 (5%) 232 (95%) <.01
 Lymphoma 15 (8%) 171 (92%) 12 (6%) 174 (94%)
 Sarcoma 9 (5%) 156 (95%) 17 (10%) 148 (90%)
 Acute leukemia 23 (15%) 131 (85%) 41 (26%) 113 (73%)
 Breast carcinoma 26 (19%) 114 (81%) 80 (57%) 60 (43%)
 Other 24 (3%) 786 (97%) 125 (15%) 685 (85%)

Abbreviation: AYAs, adolescents and young adults.